Medical Educational Resource
Congenital Myopathies: Clinical Presentation, Diagnosis, and Management
Activity Snapshot
Faculty
UT Southwestern and Children’s Health – Dallas
UT Southwestern and Children’s Health - Dallas
UT Southwestern and Children’s Health - Dallas
This CE-accredited Grand Rounds webinar focused on Congenital Myopathies features Kaitlin Batley, MD, Zurisadai Gonzalez Castillo, MD and Susan T. Iannaccone, MD, FAAN of UT Southwestern Medical Center. This webinar will cover the core clinical features and pathophysiology of these diseases, standards of care and clinical management, and will explore the current clinical research landscape and therapies on the horizon.
Upon completion of the educational activity, participants should be able to:
● Recognize the signs and symptoms of the different congenital myopathies.
● Identify the testing modalities to utilize when encountering a patient with a suspected congenital myopathy.
● Recognize the role of genetic testing in increasing the accuracy of diagnosis and optimizing patient care.
● Recognize the role of multidisciplinary care in optimizing outcomes for congenital myopathy patients.
● Refer congenital myopathy patients to relevant specialists in a timely manner.
● Incorporate recent advances in clinical studies into patient care and provide guidance on the benefits of and opportunities for participation in congenital myopathy research.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is jointly
accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
See full accreditation and designation statements and disclosure report here
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at wendi@akhcme.com.
Name Relationship Commercial Interest
Kaitlin Batley, MD:
Advisor; Sarepta therapeutics, PTC, Biogen UCB, Reata, Pfizer, Catalyst, MyTomorrows
Susan Iannaccone, MD:
Consultant; Broadstreet, Biomarin, Genentech, AveXis/Novartis, Biogen, Capricor, Catalyst, Elpida, Genentech, PTC Therapeutics, Scholar Rock, Sarepta
Researcher; RegenXBio, Reveregen, TRINDS
Zurisadai Gonzalez Castillo, MD:
Advisor; Sarepta Therapeutics
Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations: N/A, Nothing to disclose
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer): N/A, Nothing to disclose
Dorothy Duffy, RPh (planner/reviewer): N/A, Nothing to disclose
Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer): N/A, Nothing to disclose
AKH Inc Staff and Planners: N/A, Nothing to disclose
MDA Staff and Planners: N/A, Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.
